After being diagnosed with a rare and deadly form of malignant melanoma - acral lentiginous melanoma - Dr George McGavin embarks on a highly emotional and deeply personal journey as he goes through treatment for his cancer. George’s treatment is targeted drug therapy, using drugs approved for use by the NHS only weeks before his diagnosis. During this journey, he is given unprecedented access to the process and science behind his medical treatment and diagnosis. He also meets some of the most highly regarded scientists in the field of cancer research in his quest to understand not just his disease but what the future holds as a whole for cancer treatment. Amongst them are Professor Sir Michael Stratton, director of the Wellcome Sanger Institute and chief executive officer of the Wellcome Genome Campus, whose work resulted in the discovery of the mutation in the B RAF gene responsible for his form of melanoma. George also travels to Houston, Texas to meet Professor James P Allison, winner of the 2018 Nobel Prize in Medicine, to find out about his pioneering work in the field of immunotherapy - the greatest breakthrough in cancer research in a century. Back home in his own hospital, he meets a unique group of stage four melanoma patients who owe their lives to Professor Allison’s work. Ultimately, his journey culminates when he receives his prognosis, after three months of treatment, which will determine his future. Will these groundbreaking drugs actually work?
Hope you're finding these documentaries fascinating and eye-opening. It's just me, working hard behind the scenes to bring you this enriching content.
Running and maintaining a website like this takes time and resources. That's why I'm reaching out to you. If you appreciate what I do and would like to support my efforts, would you consider "buying me a coffee"?
BTC: bc1q8ldskxh4x9qnddhcrgcun8rtvddeldm2a07r2v
ETH: 0x5CCAAA1afc5c5D814129d99277dDb5A979672116
With your donation through , you can show your appreciation and help me keep this project going. Every contribution, no matter how small, makes a significant impact. It goes directly towards covering server costs.
Horizon investigates a new era of Alzheimer's research, which is bringing hope to millions of sufferers across the world. New scanning and gene technology is allowing scientists to identify the disease at its earliest stages, often 15 years before symptoms appear and the brain cells are destroyed. A series of new drugs trials in Colombia, the USA and Europe are showing startling success in reducing beta amyloid, the protein which is a hallmark of the disease. It is also becoming clear that changes in lifestyle can prevent the development of the disease. A new system inside the brain has been discovered which clears amyloid when we are in deep sleep, but allows it to accumulate if we don't sleep well. The programme reveals that for sufferers in the early stages of the disease, brain connections, or synapses, can be strengthened and even replaced by absorbing enough of the right nutrients. A UK-wide trail helps sufferers in the early stages to concentrate on improving everyday tasks, and in the process not only make their lives easier, but helps to reactivate the planning and organisational parts of the brain. In an ageing world, where the biggest risk of developing Alzheimer's is old age, the scientific breakthroughs in Alzheimer's disease are bringing hope where once there was despair.
Many clinical trials target the nation's most acute health issues. With deaths from liver disease soaring by 40 per cent in a decade, more and more patients are waiting for vital liver transplants. There is a shortage of organ donors and many donated organs are rejected as only those in excellent condition are considered suitable for a transplant procedure. Surgeons Richard Laing and Thamara Perera are part of a team at QEHB trialling a revolutionary way to tackle this crisis, by maximising the number of donor organs that can be safely re-used. The film follows the trial every step of the way, as Richard receives a donor liver that would usually be rejected and tries to prove it is viable for transplant by rejuvenating and testing it on a perfusion machine. This machine sustains the liver by mimicking the supply of blood, oxygen and nutrients an organ receives inside a live, healthy human body. Once the donor liver has proved itself fit for transplant, the surgical team start to remove grandmother Connie O'Driscoll's severely diseased liver. Once the donor liver has been disconnected from the perfusion machine, they have just 20 minutes to place it in Connie's body and plumb it into the complex and delicate network of hepatic blood vessels.
S1E3 • Surgeons: At the Edge of Life • 2018 • Health
Obesity is one of America's biggest public health concerns. Two thirds of Americans are overweight or obese. The pressure to lose weight is intense and many are turning to surgical means to achieve results.
S1E4 • A User's Guide to Cheating Death • 2017 • Health
It was 1952, and polio had reached outbreak levels in America. There was no known cause, no cure, and no help in sight for parents desperate to protect their children. Our nation's hope was placed in a 33-year-old scientist, working from a basement lab in Pittsburgh. His name was Jonas Salk, and in just a few years, he would bring infantile paralysis to its knees and change the course of medical history. Travel back to a world gripped in fear and see how Dr. Salk, with his dedicated staff, a young charity, and a faithful nation, came together to conquer polio.
2010 • Health
The Ebola virus. No-one knows exactly where it comes from but one thing is certain - it's one of the most virulent infections known to science. This special episode of Horizon meets the scientists and doctors from all around the world looking for the cure and hears first-hand accounts of what it's actually like to catch - and survive - this terrible disease.
Our skin is the largest organ in our bodies, with a surface area of about 20 square feet in adults. When we are cut or wounded, our skin begins to repair itself through a complex, well-coordinated process. Sarthak Sinha takes us past the epidermis and into the dermis to investigate this regenerative response.